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Abstract
The Vpr protein from type 1 and type 2 Human Immunodeficiency Viruses (HIV-1 and HIV-2) is thought to inactivate
several host proteins through the hijacking of the DCAF1 adaptor of the Cul4A ubiquitin ligase. Here, we identified
two transcriptional regulators, ZIP and sZIP, as Vpr-binding proteins degraded in the presence of Vpr. ZIP and sZIP
have been shown to act through the recruitment of the NuRD chromatin remodeling complex. Strikingly, chromatin is
the only cellular fraction where Vpr is present together with Cul4A ubiquitin ligase subunits. Components of the NuRD
complex and exogenous ZIP and sZIP were also associated with this fraction. Several lines of evidence indicate that
Vpr induces ZIP and sZIP degradation by hijacking DCAF1: (i) Vpr induced a drastic decrease of exogenously
expressed ZIP and sZIP in a dose-dependent manner, (ii) this decrease relied on the proteasome activity, (iii) ZIP or
sZIP degradation was impaired in the presence of a DCAF1-binding deficient Vpr mutant or when DCAF1 expression
was silenced. Vpr-mediated ZIP and sZIP degradation did not correlate with the growth-related Vpr activities, namely
G2 arrest and G2 arrest-independent cytotoxicity. Nonetheless, infection with HIV-1 viruses expressing Vpr led to the
degradation of the two proteins. Altogether our results highlight the existence of two host transcription factors
inactivated by Vpr. The role of Vpr-mediated ZIP and sZIP degradation in the HIV-1 replication cycle remains to be
deciphered.
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Introduction
Vpr is a 96-amino acid protein encoded by both HIV-1 and
HIV-2, which were cross-transmitted to humans from two
distinct primate lentiviral lineages that naturally infect
chimpanzees and sooty mangabeys respectively [1]. Vpr
belongs to the set of so-called viral auxiliary proteins, which
play a crucial role at the host-virus interface by inactivating host
restriction factors. For example, Vif induces the degradation of
APOBEC3G to avoid mutations in the viral DNA, Vpu
inactivates tetherin/BST-2 to trigger virus release and Vpx
inactivates SAMHD1 to increase the levels of dNTP, essential
precursors of viral DNA synthesis [2-8]. However, the function
of Vpr has remained elusive.
The presence of Vpr in the incoming virion argues for a role
of this protein in the early steps of the viral life cycle, before de
novo expression from integrated proviral DNA. Accordingly, an
increase in HIV-1 transduction is observed in the presence of
Vpr in macrophages and in dendritic cells [9-12]. Numerous
activities have been ascribed to Vpr, including its ability to
arrest dividing cells at the G2/M transition, to mediate a G2
arrest-independent cytotoxic effect, to activate transcription
from LTR and cellular promoters, to increase the fidelity of
reverse transcription or to induce the degradation of the UNG2
uracil DNA glycosylase (for reviews, see [13,14]). Among these
properties, the most widely studied is its ability to arrest cell
cycle progression at the G2 phase. We and others have
described a mechanism in which Vpr connects the DCAF1
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adaptor of the Cul4A ubiquitin ligase to a so far unidentified
host target protein (hereafter referred to as the G2 target),
which is required for the G2/M transition [15-21]. As a result,
the Vpr target protein undergoes poly-ubiquitination and
subsequent proteasome-mediated degradation, which
precludes cell entry into mitosis. This cytostatic activity was
shown to depend on entry into the S-phase and on the ability of
Vpr to associate with chromatin [22-24]. In addition, Vpr may
use DCAF1 to trigger a G2 arrest-independent cytotoxic effect
and to induce the degradation of UNG2 [25-27]. Whether other
Vpr activities depend on the recruitment of Cul4A is unknown.
As described for Vif and Vpu, Vpr may use the same ubiquitin
ligase to induce the degradation of several specific host
proteins. Li et al. further proposed a model in which Vpr
interaction with the hHR23A protein would be an additional
step toward the targeting of Vpr substrates to the proteasome
[28]. We now face the challenge of identifying these
corresponding target proteins, which may represent negative
cellular factors for viral growth.
The nucleosome remodeling complex Mi-2/NuRD plays a
key role in various cellular processes such as transcriptional
repression, cell cycle progression, chromatin assembly, DNA
damage response and maintenance of genome integrity (for
reviews, see [29-31]). It contains different protein subunits
which assemble in a combinatorial manner, leading to different
outcomes and cell-type specific functions. Core subunits with
enzymatic activities are chromodomain-helicase-DNA-binding
protein 3 (CHD3 or Mi2-α) and CHD4 (or Mi-2β) and histone
deacetylase 1 and 2 (HDAC1 and HDAC2). In addition to their
role within the NuRD complex, some subunits also interact with
other complexes, such as RbAp46 (also named RBBP7)
present in several chromatin modification complexes and
HDAC1 and HDAC2 found in other transcriptional repressor
complexes. The NuRD complex plays a role in normal
developmental processes, for example at different stages of
hematopoietic differentiation (reviewed in [31]). Its role in
cancer progression is not well-defined since it can promote or
suppress tumorigenesis depending on the context (reviewed in
[30]). Transcription repression by the NuRD complex is usually
mediated through its recruitment to gene promoters by a
tissue-specific transcription factor, mostly an oncogene but
sometimes a tumor suppressor. ZIP, also known as ZGPAT, is
a Zn finger and G-patch domain-containing transcription
repressor, which recruits the NuRD complex and inhibits cell
proliferation and survival, while its isoform sZIP seems to exert
an opposite effect [32,33].
Here, we identified ZIP and sZIP as direct interacting
partners of HIV-1 Vpr. Both proteins are degraded in the
presence of the viral protein via the hijacking of the DCAF1
ubiquitin ligase. Nonetheless Vpr-mediated ZIP or sZIP
degradation does not explain the cytostatic or cytotoxic
activities of Vpr.
Results
HIV-1 Vpr interacts with ZIP and sZIP
In order to identify new cellular partners of HIV-1 Vpr, an
exhaustive yeast two-hybrid screen of cDNAs from human
CEMC7 cells was performed using Vpr as bait. Among the
proteins identified with multiple prey clones were known
partners of Vpr, such as DCAF1, UNG2 or SAP145, and a new
potential partner of Vpr, the transcriptional repressor ZIP.
Alignment of prey insert sequences indicated that the domain
interacting with Vpr was confined to the C-terminal region of
ZIP (Figure 1A), a region shared by its sZIP isoform. Co-
immunoprecipitation experiments in HEK293T cells confirmed
the interaction between exogenously expressed Vpr and ZIP
(Figure 1B, compare lane 1 and 3) and between Vpr and sZIP
(Figure 1B, lane 2). Next, we asked whether Vpr and ZIP/sZIP
could be present in the same cellular compartment, since on
the one hand ZIP/sZIP associates with the NuRD chromatin
remodeling complex [32,33] and on the other hand Vpr
associates with chromatin [22,23]. We used a cellular
fractionation assay that enables the separation of five distinct
pools of proteins: cytoplasmic, membrane-bound, nuclear
soluble, chromatin-bound and insoluble proteins. We validated
the fractionation method by analyzing the localization of tubulin,
present mostly in the cytoplasmic fraction (C), histone H4,
found in the chromatin fraction (Chr), HDAC1 and MTA2
subunits of NuRD, present in the soluble fraction (SN) and in
the chromatin-associated fraction (Chr) of the nucleus and
finally RbAp46, detected in all the fractions [34-36]. Histone
acetyltransferase 1 (HAT1), a previously characterized partner
of RbAp46, was detected in the cytoplasm also confirming
previous studies showing that this enzyme shuttles between
the cytoplasm and the nucleus where it rapidly dissociates from
histones [37]. Transfected HA-Vpr was found in the five distinct
fractions, with about 2.5% of the total amount of the protein
present in the chromatin-bound fraction (Figure 1C, HA panel,
and Figure S1). The lack of valid antibodies for ZIP and sZIP
led us to study the localization of the proteins expressed from
transfected vectors. Both isoforms were found in all the
fractions, except the insoluble fraction where only ZIP could be
detected (Figure 1D). Strikingly the chromatin was the only
compartment in which both Vpr and the Cul4ADDB1 ubiquitin
ligase subunits (DCAF1, DDB1, and Cul4A) were present
together (Figure 1C). Expression of Vpr did not significantly
modify the cellular repartition of Cul4ADDB1 (Figure 1C) or the
localization of exogenous ZIP or sZIP (data not shown). Next,
we wondered whether Vpr was able to recruit the NuRD
complex, as ZIP or sZIP does [32,33]. Vpr interacted with
RbAp46, as well as with HAT1, confirming the data from Jäger
et al., obtained from a global analysis of HIV interacting cellular
partners [38] (Figure 1E). Of note, ZIP and sZIP were also able
to recruit HAT1 in addition to subunits of the NuRD complex
(Figure S2). However, Vpr did not interact with HDAC1 and
interacted weakly with MTA-2 (Figure 1E). Our data,
summarized on the scheme in Figure 1F, indicate that Vpr
recruits RbAp46, HAT1, ZIP and sZIP, in addition to the Cul4A
ubiquitin ligase.
HIV-1 Vpr induces the degradation of ZIP and sZIP
through the DCAF1 ubiquitin ligase
We next investigated how the expression levels of ZIP or
sZIP are affected by the presence of Vpr. Identical results were
obtained with sZIP (main figures) and ZIP (supplementary
Vpr-Mediated Degradation of ZIP and sZIP
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Figure 1.  Interaction of HIV-1 Vpr with ZIP and sZIP and with the NuRD complex.  A. Schema of ZIP and sZIP and Vpr-
interacting fragments. Vpr was used as bait in a yeast two-hybrid screen of oligo d(T)-primed cDNAs from human CEMC7 cells. ZIP
and sZIP isoforms are represented by boxes, with their known domains in different shades of grey. The preys matching with ZIP are
drawn as thin lines below the diagram representing ZIP and sZIP proteins. B. Vpr interacts with both ZIP and sZIP in HEK293T
cells. HEK293T cells were transfected with vectors expressing HA-tagged Vpr and the indicated FLAG-tagged proteins. Cell lysates
were prepared 48h post-transfection and subjected to immunoprecipitation using anti-FLAG antibodies. After extensive washing,
bound proteins were eluted from beads with a FLAG peptide. Immunoprecipitates (IP) and crude cell lysates (Lysates) were
analyzed by Western blotting using the indicated antibodies. C. Chromatin is the only fraction where Vpr, Cul4ADDB1 and members of
the Mi-2/NuRD complex (RbAp46, HDAC1 and MTA2) are detected together. HeLa cells were transfected with either a vector
expressing HA-tagged Vpr or an empty vector. Cells were harvested 48h post-transfection and subcellular fractionation was
performed on 2 106 cells to obtain cytoplasmic (C), membrane (M), nuclear soluble (SN), chromatin-bound (Chr) and insoluble (Ins)
protein extracts. The final volume ratio of each fraction is 2:2:1:1:1 respectively. The cellular distribution of the Vpr protein was
analyzed by Western blot, as well as the cellular distribution of the indicated endogenous proteins. D. ZIP and sZIP are detected in
the chromatin fraction. HeLa cells were transfected with vector expressing either FLAG-ZIP or FLAG-sZIP. Cells were harvested
48h post-transfection and subcellular fractionation was performed in the same conditions as described above. E. Vpr recruits
RbAp46 and HAT1 in HEK293T cells. HEK293T cells were transfected with either a vector expressing HA-tagged Vpr or an empty
vector. Cell lysates were prepared 48 h post-transfection and subjected to immunoprecipitation using anti-HA antibodies.
Immunoprecipitates (IP) and crude cell lysates (Lysates) were analyzed by Western blotting using the indicated antibodies. F.
Interactions detected between Vpr, ZIP/sZIP and the Mi-2/NuRD complex. Interactions detected by co-immunoprecipitation are
represented on this diagram. The direction of the arrow indicates the direction of the co-immunoprecipitation (base of the arrow:
immunoprecipitated protein, arrow: co-immunoprecipitated protein). Full arrows correspond to new interactions we have unraveled
here and arrows in dotted line interactions previously described and confirmed in this study [32,33,38]. Interactions between ZIP/
sZIP and HAT1, RbAp46 and HDAC1 are shown in Figure S2.
doi: 10.1371/journal.pone.0077320.g001
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figures). sZIP/ZIP was co-expressed with GFP, as an internal
control, in HeLa cells in the presence or absence of Vpr. After
cell harvesting and western blot analysis, ratios of sZIP/GFP
(or ZIP/GFP) were determined. Vpr induced a drastic decrease
of sZIP or ZIP expression in a dose-dependent manner (Figure
2A and Figure S3A respectively). Conversely, increasing the
amounts of sZIP or ZIP overcame Vpr-mediated reduction of
their expression indicating that the relative ratio of sZIP or ZIP
to Vpr determines degradation of sZIP/ZIP (Figure 2B and
Figure S3B respectively). Thereafter, we will refer to "degrading
conditions" (use of ratios that favor Vpr-mediated ZIP/sZIP
degradation) or "non-degrading conditions" (use of ratios that
do not lead to ZIP/sZIP degradation in the presence of Vpr).
Subsequent experiments were performed in "degrading
conditions" leading to about 85% decrease of sZIP or ZIP
expression. Proteasome inhibition by MG132 led to the
reversion of Vpr-mediated inhibition of sZIP expression (Figure
3A, data not shown for ZIP), suggesting that Vpr induced the
degradation of sZIP and ZIP in a proteasome-dependent
manner. Overexpression of the VprQ65R mutant, which is
impaired in its ability to recruit the DCAF1 ubiquitin ligase, did
not reduce sZIP (or ZIP) expression as efficiently as wt Vpr
(about 50% of sZIP recovered with VprQ65R compared to less
than 15% for wt Vpr, Figure 3B). The remaining effect of this
mutant on sZIP (or ZIP) expression is likely due to residual
binding to DCAF1 (data not shown). Moreover silencing of
DCAF1 completely abolished Vpr-mediated degradation of
sZIP (compare lanes 2 and 4, Figure 3C) or ZIP (compare
lanes 2 and 4, Figure S3C). Altogether, these data strongly
suggest that Vpr hijacks the DCAF1 ubiquitin ligase to induce
the degradation of sZIP and ZIP.
Vpr-mediated sZIP/ZIP degradation is not involved in
the cell growth-related Vpr activities
We further investigated whether the two cell growth-related
Vpr activities (G2 arrest and G2 arrest-independent
cytotoxicity) could result from Vpr-mediated degradation of
sZIP or ZIP. To this aim, we used previously characterized Vpr
mutants and tempted to correlate their functional phenotype
with their ability to degrade sZIP or ZIP. We first studied the
phenotype of the VprK27M mutant, which does not arrest the
cell cycle at the G2 phase but is still cytotoxic in a G2 arrest-
independent manner [26]. This mutant failed to induce the
degradation of ZIP and sZIP (Figure 4A and Figure S4A,
compare lanes 1 to 3) but still interacted with both proteins
(Figure 4B). Thus sZIP and ZIP are most likely not the cellular
factors targeted by Vpr to trigger G2 arrest-independent cell
death. A second mutant, VprS79A, which has lost its ability to
arrest the cell cycle in G2 [15,18], still interacted with both sZIP
and ZIP in vivo (Figure 4C) and induced their degradation
(Figure 4A and Figure S4A, compare lanes 1, 2 and 4). This
result suggests that sZIP and ZIP are not involved in the
cytostatic activity of Vpr, or at least that their degradation is not
sufficient for Vpr-mediated G2 arrest. We postulated that if the
degradation of ZIP or sZIP was required for the cytostatic
activity of Vpr, their overexpression would abolish Vpr-
Figure 2.  HIV-1 Vpr decreases the expression of sZIP in a dose-dependent manner.  A. HeLa cells were co-transfected with a
vector expressing FLAG-sZIP and with increasing amounts of a vector expressing HA-tagged Vpr. A GFP expression vector was
used as an internal transfection control. Cells were harvested 48h post-transfection, lysed and protein expression analyzed by
Western Blot (top panel). The histogram (bottom panel) displays the ratio between the FLAG signal and the GFP signal compared to
this ratio without Vpr. B. Same as in A except with increasing amounts of the vector expressing FLAG-sZIP, with or without HA-
tagged Vpr.
doi: 10.1371/journal.pone.0077320.g002
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Figure 3.  HIV-1 Vpr induces the degradation of sZIP through the DCAF1 ubiquitin ligase.  A. Vpr-mediated sZIP degradation
is dependent on the proteasome activity. HeLa cells were co-transfected with vectors expressing the indicated proteins. Cells were
treated 48h post-transfection with or without 20µM MG132 for 6h, harvested and lysed. Proteins expression was analyzed by
Western Blot. The left panel displays one representative experiment; the histogram shows the fold increase of sZIP expression
(ratio over GFP) induced by MG132 with and without Vpr (7 independent experiments, p-value≈0.001). B. The DCAF1 binding-
deficient Vpr mutant, VprQ65R, is less efficient than wt Vpr to induce sZIP degradation. HeLa cells were co-transfected with vectors
expressing FLAG-sZIP, HA-tagged Vpr proteins as indicated and a GFP expression vector as an internal control (ratio 10:1). Cells
were harvested 48h post-transfection, lysed and protein expression was analyzed by Western Blot (left panel, one representative
experiment). The histogram shows the quantification of the ratio between the FLAG and GFP signals for 7 independent
experiments. C. Silencing of DCAF1 impairs Vpr-induced sZIP degradation. HeLa cells were treated with either 50nM of control
siRNA or with 50nM of siRNA directed against DCAF1. Cells were transfected 24h later with vectors expressing the indicated
proteins. Cells were harvested 48h post-transfection, lysed and the proteins expression analyzed by Western Blot (left panel, one
representative experiment). The histograms (right panel) display the ratios between FLAG and GFP signals.
doi: 10.1371/journal.pone.0077320.g003
Vpr-Mediated Degradation of ZIP and sZIP
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mediated G2 arrest. We conducted a cell cycle experiment in
which exogenous ZIP and sZIP were expressed in HeLa cells
one day prior to the delivery of Vpr with virus-like-particles
(VLPs). Cell cycle analysis was carried out 18 hours after Vpr
delivery. In these "non-degrading conditions" (see western blot
Figure 4D, bottom panel), the presence of ZIP or sZIP did not
affect Vpr-mediated G2 arrest (Figure 4D, upper panel). This
result further indicates that ZIP and sZIP are not involved in the
cytostatic activity of Vpr. We also analyzed the ability of Vpr
proteins from distinct lentiviral lineages to induce the
degradation of sZIP or ZIP. Vpr from SIVmnd-2, which is able
to induce G2 arrest ( [26] and Figure S5), mediated the
degradation of both isoforms as efficiently as Vpr from HIV-1
(Figure 4E and Figure S4B, compare lanes 1, 2 and 5) and Vpr
from SIVdrl, which does not induce G2 arrest (Figure S4C),
failed to induce the degradation of sZIP and ZIP (Figure 4E and
Figure S4B). However, despite their ability to arrest the cell
cycle [26,39], the Vpr proteins from SIVrcm and SIVmac251
failed to induce the degradation of ZIP or sZIP. Therefore, the
ability of Vpr to induce sZIP or ZIP degradation did not
correlate with its ability to induce cell cycle arrest in human
cells. Altogether, our results discard sZIP and ZIP as the
cellular factors targeted by Vpr to induce cell cycle arrest at the
G2 phase.
In an attempt to understand the role of ZIP and sZIP in the
viral life cycle, we wondered whether the two proteins could
interfere with HIV-1 LTR-driven viral transcription. HeLa cells
were transfected with increasing doses of vectors expressing
ZIP or sZIP, then infected with a VSV-G pseudotyped HIV-1
virus expressing luciferase (pNL4.3LucΔEnvΔVpr).
Quantification of luciferase showed that ZIP and sZIP failed to
repress or activate LTR-driven transcription in HeLa cells
(Figure S5A).
We further asked whether the two transcription factors could
be degraded in the context of viral infection. HEK293 cells were
first transfected with vectors encoding ZIP and sZIP, then
infected with HIV-1 viruses lacking or encoding the Vpr gene or
bearing the Vpr gene mutated at the Q65 residue. Expression
of sZIP and ZIP was reduced in the presence of wt viruses but
not when Vpr was deleted or mutated on its DCAF1 binding
site (Figures 5 and S5B).
Discussion
We uncovered ZIP as a new HIV-1 Vpr-interacting partner
with a high confidence score in a two-hybrid screen. We
considered ZIP and its isoform sZIP as potential Vpr targets for
several reasons: (i) Vpr binds to chromatin, (ii) ZIP and sZIP
recruit the NuRD chromatin remodeling complex and (iii) these
two proteins play a role in cell proliferation and survival. We
found that Vpr induced ZIP and sZIP degradation through the
use of the DCAF1 adaptor of the Cul4ADDB1 ubiquitin ligase.
The physiological relevance of this phenomenon regarding
HIV-1 remains uncertain. However, degradation of
overexpressed ZIP or sZIP also occurred in the context of
infection by HIV-1 viruses bearing a wt Vpr gene and not the
corresponding DCAF1-binding deficient mutant.
Previous reports have shown that Vpr associates with
chromatin, though the percentage of Vpr bound to the
chromatin fraction was not determined [22,23,40,41].
Importantly, biochemical and immunofluorescence approaches
showed that Vpr could form a complex with DCAF1 on
chromatin [22]. In addition, Cul4ADDB1 is an ubiquitin ligase
specialized in the degradation of substrates present in the
vicinity of the chromatin [42]. The finding that the chromatin
fraction is the only one in which Vpr, DCAF1, DDB1 and Cul4A
are present together nicely fits with these data, reinforcing the
idea, previously raised by Belzile et al., that Vpr may induce the
degradation of cellular targets on the chromatin [22].
Nonetheless, in our hands most of the nuclear portion of Vpr
was soluble and only less than 3% of the viral protein was
tightly bound to the chromatin. This poor recruitment of Vpr to
chromatin could result from our experimental procedure, in
which the chromatin fraction contains proteins only tightly
bound to chromatin. In any case, a small amount of the viral
protein should be sufficient to ensure its activities through an
ubiquitin ligase enzymatic activity. In a similar way, Precious et
al. underscored a catalytic process, where a small pool of SV5
V protein is recycled in order to degrade a large excess of
STAT1 through the use of Cul4ADDB1 [43].
Our interest in NuRD was driven by the fact that both ZIP
and sZIP were shown to recruit this chromatin remodeling
complex [32,33]. Interestingly, RbAp46, HDAC1 and MTA2 on
the one hand and ZIP and sZIP expressed from transfected
vectors on the other hand were present in the chromatin
fraction. Of note, Vpr interacted with RbAp46, weakly with
MTA2 but not with every constituent of the NuRD complex and
namely not with HDAC1. Unfortunately, no Vpr mutant,
defective for ZIP or sZIP interaction, could be isolated so far.
Altogether, our data suggest that Vpr might be present within a
sub-complex, containing ZIP (or sZIP), RbAp46 and HAT1
(Figure 1F, dotted-line box).
The dose-dependent effect we have noticed regarding Vpr-
mediated ZIP or sZIP degradation was also reported in the
case of UNG2 [27]. In both examples, the ratio of Vpr over the
cellular target is critical for degradation to occur. Different
physiological outcomes may result from the interaction
depending on this ratio. Further work is required to determine
the relative expression of ZIP and sZIP in primary cells relevant
for HIV infection.
Over the past years, many cellular partners of Vpr have been
identified and new interactions are still being unravelled. The
relevance of these interactions is sometimes difficult to assess.
Studying the role of Vpr-ZIP (or sZIP) interaction suffers from a
lack of a clear in vitro culture system where HIV-1 replication
would show a strong dependence on the presence of the viral
protein. Indeed, it is only in such a system that the cellular
target inactivated by Vpr is expected to display an antiviral
activity. Similarly, specific cellular systems are essential to
highlight the activity of cellular restriction factors against HIV. In
these cells, the restriction factor is both present and active. For
example, the antiviral activity of the SAMHD1 restriction factor
can only be unravelled in quiescent cells, where its viral
counterpart, Vpx, enhances HIV-1 transduction [2,7,8]. In a
system where the activity of Vpr could be easily monitored,
Vpr-Mediated Degradation of ZIP and sZIP
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Figure 4.  Vpr-mediated sZIP degradation does not correlate with the G2 arrest-independent cytotoxicity activity of Vpr, nor
with its ability to trigger G2 arrest.  A. Characterization of Vpr mutants for their ability to trigger the degradation of sZIP. HeLa
cells were co-transfected with vectors expressing FLAG-sZIP and the indicated HA-tagged Vpr proteins and a GFP expression
vector as an internal control (ratio 10:1). Cells were harvested 48h post-transfection, lysed and proteins expression was analysed by
Western Blot. The top panel displays the results of one representative experiment. The bottom panel shows the quantification of the
ratio between FLAG and GFP signals for several independent experiments. B and C. G2 arrest-defective Vpr mutants, VprK27M
and VprS79A, still interact with ZIP and sZIP. HEK293T cells were transfected with vectors expressing HA-tagged Vpr mutants,
VprK27M (B) and VprS79A (C), and a vector expressing the indicated FLAG-tagged proteins. Cell lysates were prepared 48h post-
transfection and subjected to immunoprecipitation using anti-FLAG antibodies as described in Figure 1B. D. Overexpression of ZIP
or sZIP does not overcome Vpr-mediated G2 arrest. HeLa cells were co-transfected with vectors expressing either FLAG-ZIP or
FLAG-sZIP along with a vector expressing the GFP protein. 24h post-transfection, the cells were incubated with empty VLP or VLP
containing wt Vpr protein for 2 h (800 ng GAG CAp24 per VLP). The cells were harvested 18h after the VLP treatment. Half the cells
were fixed, stained with propidium iodide and analyzed by flow cytometry to monitor the DNA content of the GFP-positive population
(top panel). The other half of the cells were lysed and protein expression was analyzed by Western Blot (bottom panel). E.The Vpr-
induced sZIP degradation has some Vpr-species specificity (which does not correlate with Vpr-species specificity towards cell cycle
arrest). HeLa cells were co-transfected with a vector expressing FLAG-sZIP together with a vector expressing the indicated HA-
tagged Vpr proteins. GFP was used as an internal control as in A. Cells were harvested 48h post-transfection, lysed and protein
expression was analyzed by Western Blot (top panel). The bottom panel shows the ratios between FLAG and GFP signals. The G2
arrest activity of each Vpr protein in Hela cells is indicated below the histogram.
doi: 10.1371/journal.pone.0077320.g004
Vpr-Mediated Degradation of ZIP and sZIP
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suppression of the expression of ZIP or sZIP by siRNA would
be a valuable tool to demonstrate a potential antiviral activity
associated with these cellular proteins.
The situation is even more complicated with Vpr since Vpr
likely uses the same ubiquitin ligase, Cul4ADDB1, to inactivate
Figure 5.  Vpr expressed following infection with HIV-1
reduces exogenous sZIP expression levels.  293T cells
were co-transfected with equal amounts of empty or FLAG-
sZIP-expressing plasmid in the presence of a GFP expression
vector as an internal transfection control (ratio 10:1). After 24h
the cells were mock infected or infected with two doses of the
indicated HIV-1 viruses (50 and 250 ng of GAG CAp24 per 105
cells). Two days post-infection the cells were lysed and
expression levels of FLAG-sZIP, GFP and GAG products were
assessed by western-blot in the whole cell extracts (top panel).
The histogram (bottom panel) displays the FLAG/GFP signal
ratios.
doi: 10.1371/journal.pone.0077320.g005
several proteins that may display an antiviral activity in different
settings. Indeed, on the one hand, we have provided genetic
evidence that Vpr hijacks Cul4ADDB1 to arrest the cell cycle and
to induce a G2 arrest-independent cytotoxicity phenotype
[18,26]. On the other hand, Vpr has been reported to use
Cul4ADDB1 to inactivate several distinct proteins, namely Mfn2,
Ung2 and Dicer [25,44,45]. Similarly, the E6 protein from
papillomavirus targets a wide range of cellular proteins for
proteasome-mediated degradation, including p53, the Bcl-2
family member Bak and many other targets containing class 1
PDZ domains including Akt, Dlg and Scribble (for a review, see
[46]).
Cellular proteins inactivated by Vpr might share some
structural or functional features. Keeping in mind that (i) UNG2
is a glycosylase that removes uracil near replication forks; (ii)
that the G2 target is thought to be present in the vicinity of the
chromatin [22]; (iii) that ZIP/sZIP are NuRD binding partners
and (iv) that Cul4A and DDB1 are present mostly in the
chromatin fraction, a common feature of the Vpr targets might
be their association with chromatin, at least when degradation
occurs.
Vpr-mediated ZIP or sZIP degradation correlated neither with
the most studied property of Vpr, i.e. its ability to induce G2
arrest, nor with its G2 arrest-independent cytotoxic property.
Interaction of Vpr with ZIP or sZIP could be involved in some
other Vpr activity, namely its ability to trans-activate the LTR or
to modulate transcription from cellular promoters [47-58]. We
have not investigated this hypothesis yet because of the lack of
Vpr mutants for such activities. In addition, we found that
overexpression of ZIP or sZIP did not affect transcription driven
from the HIV-1 promoter in HeLa cells. Future work will be
needed to assess whether Vpr interferes with the
transcriptional activities of ZIP and sZIP in order to provide an
advantageous environment for viral replication and
dissemination. A comparative transcriptional profiling of cells
expressing or not Vpr could help gain some insight into the
function of Vpr.
Materials and Methods
Plasmid constructs.
pAS1B vectors encoding HA-tagged Vpr from HIV-1 LAI, Vpr
from SIVrcm, Vpr from SIVmnd2 and Vpr from SIVmac251
have been previously described [18,26,59]. The Vpr gene
corresponding to SIVdrl was synthesized by GeneCust Europe
following codon optimization for expression in human cells and
then inserted into the pAS1B vector. Plasmids encoding ZIP
and sZIP fused to the FLAG tag at the N-terminus have been
previously described [32,33]. The internal membrane-anchored
GFP was expressed from the pBabe/GEM2 vector [60].
Yeast Two-Hybrid analysis
The coding sequence for full-length YU2 VPR (nt5557 to nt
5850) was PCR-amplified and cloned into pB27 as a C-terminal
fusion to LexA. The constructs were used as baits to screen at
saturation a highly complex dT-primed human CEMC7 library.
60.3 million clones (6-fold the complexity of the library) were
screened using a mating approach with Y187 (mata) and
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L40DGal4 (mata) yeast strains as previously described [61].
His+ LacZ+ colonies were grown on a medium lacking
tryptophan, leucine, and histidine. 265 colonies were selected.
The prey fragments of the positive clones were amplified by
PCR and sequenced at their 5p junction. The resulting
sequences were used to identify the corresponding interacting
proteins in the GenBank database (NCBI), using a fully
automated procedure. Briefly, 5p sequences were filtered using
PHRED. Sequence contigs were built using CAP3 and
compared to the latest release of GenBank using BLASTN [62].
14 clones coding for ZIP were selected with 8 different fusions.
Cell culture, transfection procedures and reagents
HeLa and HEK293T cells were maintained in DMEM
supplemented with glutamine and 10% fetal calf serum.
Plasmid transfections were performed using Fugene 6
Transfection reagent (Roche) and siRNA transfections were
performed using Dharmafect reagent (Dharmacon). Control
and DCAF1 siRNAs were purchased from Dharmacon. The
following siRNA was used to target DCAF1: 09,
ggagggaaUUgucgagaauuu. The proteasome inhibitor MG132
was purchased from Sigma and used at a final concentration of
20µM for 6 hours.
Subcellular fractionation assay
The subcellular fractionation was carried out using the
“Subcellular Protein Fractionation” kit from Pierce according to
the manufacturer’s instructions. Briefly, 2x106 HeLa cells were
lyzed with successive buffers, in the presence of protease
inhibitors, allowing the successive extraction of soluble
cytoplasmic proteins, membrane-bound proteins, soluble
nuclear proteins and then chromatin-bound proteins (issued
from micrococcal nuclease digestion), leaving insoluble
proteins in the remaining pellet. The ratio of the final volume of
each fraction is 2:2:1:1:1.
Anti-FLAG immunoprecipitation procedure
Cells grown in 10-cm dishes were lyzed in 700µl SD buffer
(50mM Tris‑HCl pH 7.5, 150mM NaCl, 0.5% Triton X100)
containing an anti-protease cocktail (Sigma). Cell lysates were
clarified by centrifugation and incubated with anti-FLAG beads
(EZview™ Red ANTI-FLAG® M2 Affinity Gel, Sigma) overnight
at 4°C. After four washes in SD buffer, immunoprecipitated
proteins were recovered by elution with Flag peptide (Sigma)
for one hour at 4°C.
Anti-HA immunoprecipitation procedure
Cells grown in 10-cm dishes were lyzed in 700µl SD buffer
containing an anti-protease cocktail (Sigma). Cell lysates were
clarified by centrifugation and incubated with anti-HA beads
(Anti-HA Affinity Matrix, Roche) over-night at 4°C. After four
washes in SD buffer, immunoprecipitated proteins were
recovered by elution with HA peptide (Roche) for one hour at
37°C.
Western blot procedure and antibodies
Cells were lyzed in 500µl SB buffer (60mM Tris pH 8, 10%
Glycerol, 2% SDS, 1% bromophenol blue, 100mM DTT) using
a 27G needle and protein extracts were separated by SDS-
PAGE electrophoresis. Following transfer onto PVDF
membranes, proteins were revealed by immunoblot analysis
using a chemiluminescent procedure (CDPStar®, Applied
Biosystems). Signals were acquired by a LAS 3000 apparatus
(Fujifilm) for further quantification, using the Multigauge
software (Fujifilm). Monoclonal antibody directed against the
HA (16B12) tag was purchased from Covance Research
Products; anti-GFP from Roche; anti-FLAG M2 and anti-
Tubulin monoclonal antibodies from Sigma, anti-Cullin4A and
RbAp46 rabbit polyclonal antibodies and anti-MTA2 mouse
monoclonal antibody from Abcam; anti-Histone H4 and anti-
HDAC1 rabbit polyclonal antibodies were purchased from Cell
Signaling; anti-DCAF1 rabbit polyclonal antibody was obtained
from Gentaur; anti-DDB1 mouse monoclonal antibody was
purchased from Zymed and anti-HAT1 mouse monoclonal
antibody was purchased from Santa Cruz.
Virus production
For the delta-Env HIV-1 viruses (DHIV), 293T cells (4 × 106
cells) were co-transfected with pNL4.3 deltaEnv HIV-1
constructs lacking the gene encoding Vpr (DHIV ΔVpr) or
encoding either wt Vpr (DHIV wt) or VprQ65R (DHIV VprQ65R)
[63] along with a plasmid encoding the vesicular stomatitis
virus glycoprotein G (VSV-G). For the luciferase reporter
viruses, 293T cells were co-transfected with a pNL4.3
deltaEnv-deltaVpr HIV-1 construct expressing the luciferase
protein instead of Nef [10] along with the plasmid encoding
VSV-G. For the pseudoparticles (VLPs), 293T cells were
cotransfected with HIV-1 minimal packaging vector
pCMVdelta8.91 [11] along with the plasmid encoding VSV-G
and a plasmid encoding HA-tagged Vpr in a ratio of 5:1:5. The
culture supernatants were collected 48h after transfection and
filtered through 0.45-µm pore filters. The viral particles were
then concentrated in 10% polyethylene-glycol 6000
(PEG-6000) (Sigma) containing 300mM NaCl and titrated by
quantification of HIV-1 capsid p24 using an enzyme-linked
immunosorbent assay (ELISA) (ZeptoMetrix Corporation).
Luciferase activity assay
The luciferase activity was measured using the Dual-
Luciferase® Reporter Assay from Promega according to the
manufacturer’s instructions. Briefly, cells expressing luciferase
were washed twice with PBS and lysed directly in wells using
1X Passive Lysis Buffer for 15 minutes at room temperature.
Cell lysates were clarified by centrifugation and the luciferase
activity was measured using Luciferase Assay Substrate with a
FLUOstar OPTIMA from BMG LABTECH.
Cell cycle analysis
5x105 HeLa cells were plated onto 6-cm dishes 24 hours
prior to transfection. The cells were transfected with 1 µg of
pAS1B-Vpr in combination with 0.1 µg of pBabe/GEM2 as an
internal transfection marker. Twenty-four hours later, the cells
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were harvested and plated onto 10-cm dishes and grown for
one more day. The cells were then detached (manually) and
fixed in 70% ethanol. Following treatment for 30 minutes at
37°C with 0.2 mg/ml RNase A and 50 µg/ml propidium iodide in
buffer H (20 mM Hepes, 160 mM NaCl, 1 mM EGTA), cells
expressing the cotransfected GFP were analyzed for their DNA
content using a Cytomics FC500 cell analyzer (Beckman
Coulter). At least 10,000 GFP-positive cells were analyzed for
their distribution in the different phases of the cell cycle.
Supporting Information
Figure S1.  Only a small fraction of Vpr is detected in the
chromatin-associated proteins fraction. The histogram
displays the quantification of HA signal in each fraction,
expressed as a percentage of the total HA signal for cells
expressing HA-Vpr WT from the Western blot displayed in
Figure 1C.
(TIF)
Figure S2.  ZIP and sZIP interact with subunits of the Mi2/
NuRD complex and with HAT1, a partner of RbAp46.
HEK293T cells were transfected with vectors expressing HA-
tagged Vpr and the indicated FLAG-tagged proteins. Cell
lysates were prepared 48h post-transfection and subjected to
immunoprecipitation using anti-FLAG antibodies. After
extensive washing, bound proteins were eluted from beads
with a FLAG peptide. Immunoprecipitates (IP) and crude cell
lysates (Lysates) were analyzed by Western blotting using the
indicated antibodies.
(TIF)
Figure S3.  HIV-1 Vpr induces the degradation of ZIP
through the DCAF1 ubiquitin ligase. A and B. HIV-1 Vpr
decreases the expression of ZIP in a dose-dependent manner.
A. HeLa cells were co-transfected with a vector expressing
FLAG-ZIP and with increasing amounts of a vector expressing
HA-tagged Vpr. A GFP expression vector was used as an
internal transfection control. Cells were harvested 48h post-
transfection, lysed and protein expression analyzed by Western
Blot (top panel). The histogram (bottom panel) displays the
ratio between the FLAG signal and the GFP signal compared
to this ratio without Vpr. B. Same as in A except with increasing
amounts of the vector expressing FLAG-ZIP, with or without
HA-tagged Vpr. C. Silencing of DCAF1 impairs Vpr-induced
ZIP degradation. HeLa cells were treated with either 50nM of
control siRNA or with 50nM of siRNA directed against DCAF1.
Cells were transfected 24h later with vectors expressing the
indicated proteins. Cells were harvested 48h post-transfection,
lysed and the proteins expression analyzed by Western Blot
(left panel, one representative experiment). The histograms
(right panel) display the ratios between FLAG and GFP signals.
(TIF)
Figure S4.  Vpr-mediated ZIP degradation does not
correlate with the G2 arrest-independent cytotoxicity
activity of Vpr, nor with its ability to trigger G2 arrest. A.
Characterization of Vpr mutants for their ability to trigger the
degradation of ZIP. HeLa cells were co-transfected with vectors
expressing FLAG-ZIP and the indicated HA-tagged Vpr
proteins and a GFP expression vector as an internal control
(ratio 10:1). Cells were harvested 48h post-transfection, lysed
and proteins expression was analysed by Western Blot. The
top panel displays the results of one representative experiment.
The bottom panel shows the quantification of the ratio between
FLAG and GFP signals for several independent experiments.
B. The Vpr-induced ZIP degradation has some Vpr-species
specificity (which does not correlate with Vpr-species specificity
towards cell cycle arrest). HeLa cells were co-transfected with
a vector expressing FLAG-ZIP together with a vector
expressing the indicated HA-tagged Vpr proteins. GFP was
used as an internal control as in A. Cells were harvested 48h
post-transfection, lysed and protein expression was analyzed
by Western Blot (top panel). The bottom panel shows the ratios
between FLAG and GFP signals. The G2 arrest activity of each
Vpr protein in Hela cells is indicated below the histogram. C.
SIVdrl Vpr does not induce a cell cycle arrest at the G2/M
transition. HeLa cells were transfected with vectors expressing
the indicated HA-tagged proteins along with a vector
expressing the GFP protein. Cells were harvested 48 h post-
transfection. After fixation and propidium iodide staining, the
cells were analyzed by flow cytometry to monitor the DNA
content of the GFP-positive population. The G2/G1 ratio is
indicated above each diagram.
(TIF)
Figure S5.  A. ZIP and sZIP do not affect transcription from
the LTR promoter in HeLa cells. HeLa cells were transfected
with vectors expressing either FLAG-ZIP or FLAG-sZIP (1.5
and 3 µg of each). Cells were then infected 24h post-
transfection with VSV-G pseudo-typed pNL4.3LucΔEnvΔVpr at
MOI 0.5. Cells were harvested 48h post-infection, lysed and
the luciferase activity was measured using a FLUOstar
OPTIMA from BMG Labtech (AU, Arbitrary Units) (top panel).
The experiment was performed in triplicate. Expression levels
of FLAG-ZIP and FLAG-sZIP were determined by western blot
(bottom panel.) B. Vpr expressed following infection with
HIV-1 decreases exogenous ZIP expression. 293T cells
were co-transfected with equal amounts of empty or FLAG-ZIP-
expressing plasmid in the presence of a GFP expression
vector. Twenty four hours post-transfection, cells were infected
with two doses of the indicated HIV-1 viruses (50 and 250 ng of
GAG CAp24 per 105 cells). Two days post-infection the cells
were lysed and expression levels of FLAG-ZIP, GFP and GAG
products were assessed by western-blot in the whole cell
extracts.
(TIF)
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